Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674825 | SCV000800226 | likely pathogenic | Classic homocystinuria | 2018-05-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531362 | SCV003288977 | pathogenic | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2023-03-21 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CBS-related conditions. This sequence change creates a premature translational stop signal (p.Arg51Serfs*27) in the CBS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CBS are known to be pathogenic (PMID: 10338090, 12124992). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 558538). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003327444 | SCV004034317 | likely pathogenic | not provided | 2024-06-06 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |